News Focus
News Focus
icon url

flipper44

12/05/24 6:16 AM

#735732 RE: Single Stock #735731

Would you agree with this?

The borrowing fee is a key distinction between legitimate short selling and naked short selling.

Here's a breakdown:

Legitimate Short Selling:

The trader borrows shares from a lender.  
The trader pays a fee to the lender for borrowing the shares.  
The trader sells the borrowed shares on the open market.  
The trader must eventually buy back the shares to return to the lender.  

Naked Short Selling:

The trader sells shares they don't own or haven't borrowed.  
This creates a "fake" supply of shares, which can artificially depress the stock price.  
The trader doesn't pay a borrowing fee because they haven't borrowed any shares.  
While regulators have implemented measures to curb naked short selling, it's still a complex issue. Sophisticated traders may use various techniques to disguise their activities, making it difficult for regulators to detect and enforce against. However, the borrowing fee remains a fundamental indicator that can help distinguish between legitimate and illegitimate short selling practices

.   AI Gemeni

Continued

The key to understanding naked short selling lies in the intricacies of the settlement process and the role of market makers.

While it's illegal to sell shares you don't own without borrowing them, there can be instances where a trader, often a market maker, might sell a stock short without immediately having the shares to deliver. This can occur due to various reasons, such as:

Market Maker Obligations: Market makers are obligated to provide liquidity to the market. In certain situations, they might sell a stock short to facilitate a trade, even if they don't have the shares on hand at that exact moment.

Settlement Delays: The settlement process for stock trades can take a few days. During this period, there's a potential for discrepancies, and in some cases, naked short positions might arise unintentionally.

Regulatory Loopholes: Despite efforts to regulate naked short selling, there can be loopholes and gray areas that some traders may exploit.

It's important to note that while these practices might technically be legal, they can still have negative consequences for the market, including price manipulation and market instability. Regulators are constantly working to tighten rules and improve surveillance to prevent such activities.

However, as you've pointed out, the exact mechanics of naked short selling can be difficult to pinpoint, especially in complex market environments. While market makers may have more opportunities to engage in naked short selling due to their role in the market, they are still subject to the same laws and regulations as other market participants. If caught engaging in naked short selling, market makers can face significant penalties, including fines and even imprisonment

AI Gemeni
icon url

theorysuit

12/05/24 6:32 AM

#735734 RE: Single Stock #735731

This should not be surprising unless you believe the company and their paid pumpers. Should be fortunate that it still holds that 300M market cap with nothing to their name in cash. It clearly isn't undervalued if you are paying attention. The salvage value aka advent is wholly owned by LP. The gmp and mia owned by advent holds the only value worth anything with a rejection.
icon url

flipper44

12/05/24 6:47 AM

#735736 RE: Single Stock #735731

Would you agree that the legal shorting percentage against NWBO would, on the surface, point to it being a low risk stock?
icon url

manibiotech

12/05/24 7:24 AM

#735744 RE: Single Stock #735731

Well said
icon url

Jackxkr

12/05/24 8:25 AM

#735752 RE: Single Stock #735731

This sounds spot on. It is mgmt who cannot raise healthy money for the most part and lies with snakes. If Dvax is so revolutionary and life changing there must have been deals that LP turned down , I can't see how there wasn't which I believe now that is why our chickens are coming home to roost ( hopefully not die) by the way of crashing share price. All the cult you still glad you voted bonus shares for this cast of big red floppy shoe wearing mgmt of ours? You probably would vote them more shares this Xmas if they asked. You sirs are red floppy boot shoe licking idiots. Other than a said few no one here holds mgmt accountable for anything , just cult followers.

Happy Thursday ( bet another red day)
icon url

dstock07734

12/05/24 8:54 AM

#735762 RE: Single Stock #735731

Will LP still need money after the approval? The answer is no. Any BPs in oncology business would have to connect with NWBO one way or another.

See this paper? When was it published? 2016. Was it the same year the company was pushed to OTC? The DC vaccine has amazing efficacy for most children patients with three tough pediatric sarcomas either metastatized or recurrent. Over 30% patients were cancer free five years after the treatment. No way LP would let the dark forces go without paying hefty price. The lawsuit should and will go to the stage when the jury gives the verdict.

https://aacrjournals.org/clincancerres/article/22/13/3182/79179/Adjuvant-Immunotherapy-to-Improve-Outcome-in-High